The use of MRI for breast cancer screening is recommended by the American Cancer Society for women with a 20% to 25% or greater lifetime risk using risk assessment tools:
BRCA mutation carriers
Individuals who have a family member with a BRCA mutation who have not been tested
Individuals who received radiation to the chest between the ages of 10 to 30 years
Individuals with a history of Li-Fraumeni syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome or those who have a first-degree relative with one of these syndromes
References
Schwartz’s 10th ed (http://amzn.to/1q10JSc)